United States · FDA National Drug Code directory
Tizanidine HCL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0090_453cd7ac-cee0-2b91-e063-6294a90afcdc
- Product NDC
- 80425-0090
- Form
- CAPSULE
- Composition / generic term
- Tizanidine HCL
- Labeler
- Advanced Rx of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190320
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (80425-0090-1) · 80425-0090-1
- 90 CAPSULE in 1 BOTTLE (80425-0090-2) · 80425-0090-2
- 30 CAPSULE in 1 BOTTLE (80425-0090-3) · 80425-0090-3
- 120 CAPSULE in 1 BOTTLE (80425-0090-4) · 80425-0090-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →